Investigational TAK-003 Vaccine Remained Effective At Protecting Against Symptomatic Dengue Fever In Pediatric Patients, Three-Year Data Show

Infectious Disease Advisor (11/3, Nye) reports, “At 3 years, the TAK-003 vaccine from Takeda remained effective at protecting against symptomatic dengue fever among children and adolescents,” according to findings from an ongoing phase 3 trial published i...